Clinical Topics & News

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man

Author and Disclosure Information

 

References

Conclusion

This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he was treated with appropriate and well-dosed therapy. Ultimately, his unmodifiable immunosuppression was likely the driving factor leading to treatment failure and death. The indication for and number of bone marrow transplants continues to increase, thus exposure to and treatment of invasive fungal infections will increase accordingly. As such, providers should ensure that all causes of treatment failure are considered and addressed.

Pages

Recommended Reading

CNS-directed therapy appears more effective for synDLBCL
Federal Practitioner
No reduction in PE risk with vena cava filters after severe injury
Federal Practitioner
R2-CHOP doesn’t improve survival in DLBCL
Federal Practitioner
Ibrutinib tops chlorambucil against CLL
Federal Practitioner
Another study supports safety of 2-cm margins for thick melanomas
Federal Practitioner
SC daratumumab deemed feasible for every multiple myeloma patient
Federal Practitioner
Gaps in patient-provider survivorship communication persist
Federal Practitioner
NOACs benefit early stage chronic kidney disease patients
Federal Practitioner
Ibrutinib-venetoclax found highly active in hard-to-treat CLL
Federal Practitioner
BRCA2 mutations linked to childhood NHL
Federal Practitioner